Uploaded on Feb 1, 2023
Neurological diseases having less diagnostics and treatment options affecting small number of population is termed as rare neurological diseases. These diseases target the nervous system, which include the brain, spinal cord, and all the nerves that run throughout the human body. Read More:- https://www.theinsightpartners.com/reports/rare-neurological-disease-treatment-market
Rare Neurological Disease Treatment Market Global Industry Growth, Size, Trends, Insights and 2027 Forecast
Rare Neurological Disease Treatment Market Global Analysis and Forecast to 2027
Published Date : Mar 2020
Email: [email protected]
Email: [email protected]
Report Studies
Rare Neurological Disease Treatment Market to 2027 - Global Analysis and
Forecasts by Indication (Narcolepsy, Amyotrophic Lateral Sclerosis, Alzheimer's
Disease, Multiple Sclerosis, Spinal Muscular Atrophy (SMA), Duchenne Muscular
Dystrophy, Other Indication); Drug Type (Organic Compounds, Biologics);
Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies);
Mode of Administration (Oral, Injectables) and Geography
2
Email: [email protected]
$50,000
Rare Neurological
Disease Treatment $40,000
Market Value
$30,000
CAGR of 8.5%
$20,000
(2020 to 2027)
$10,000
$0
20XX 20XX 20XX 20XX 20XX
3
Email: [email protected]
Rare Neurological Disease
Treatment Market Overview
The Rare Neurological Disease Treatment Market is expected to reach US$13,830.96 Mn in
2027 from US$ 7,300.12Mn in 2019. The market is estimated to grow with a CAGR of 8.5%
from 2020-2027.
Neurological diseases having less diagnostics and treatment options affecting small number
of population is termed as rare neurological diseases.
4
Email: [email protected]
Key Segment Market
Segment By Type:-
Indication (Narcolepsy, Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Multiple
Sclerosis, Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy, Other Indication)
Drug Type (Organic Compounds, Biologics)
Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies)
Mode of Administration (Oral, Injectables)
5
Email: [email protected]
Company Profiles
Allergan plc
Bayer AG
GlaxoSmithKline plc
Johnson & Johnson Services Inc
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd
Takeda Pharmaceutical
6
Download Sample Her
e
Email: [email protected]
By Geography
North America (the US, Canada, and Mexico)
Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)
Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)
Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East &
Africa)
South & Central America (Brazil, Argentina, and the Rest of South & Central America).
7
THANK
YOU! Phone : +1-646-491-9876
E-Mail : [email protected]
Comments